SCHEMBL4770929

SCHEMBL4770929

CS(=O)(=O)N(Cc1cccc(Cl)c1Cl)c1ccc(C(=O)NCCCN2CCCCC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.51
SLC6A2 P23975 2/20 0.49
SLC6A4 P31645 2/20 0.49
GAA P10253 1/20 0.48
NPSR1 Q6W5P4 1/20 0.47
DRD3 P35462 6/20 0.47
DRD2 P14416 5/20 0.47
DRD4 P21917 5/20 0.47
HTR1A P08908 1/20 0.47
ADRA1D P25100 1/20 0.47
ADRA1A P35348 1/20 0.47
ADRA1B P35368 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.45
LMNA P02545 2/20 0.45
KMT2A Q03164 1/20 0.45
MAPT P10636 1/20 0.44
RECQL P46063 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5572112 0.99 ALDH1A1 (0.52) ALDH1A1SLC6A2SLC6A4GAANPSR1
SCHEMBL5571358 0.94 ALDH1A1 (0.54) ALDH1A1GAANPSR1DRD3DRD2
SCHEMBL4795230 0.93 ALDH1A1 (0.56) ALDH1A1SLC6A2SLC6A4GAADRD3
SCHEMBL4777569 0.91 CA12 (0.51) ALDH1A1GAAHTR1ASMN1; SMN2LMNA
SCHEMBL4777371 0.87 ALDH1A1 (0.57) ALDH1A1SLC6A2SLC6A4GAANPSR1
SCHEMBL5571919 0.87 CACNA1G (0.54) ALDH1A1GAARECQL
SCHEMBL5571820 0.86 L3MBTL1 (0.52) ALDH1A1SMN1; SMN2KMT2A
SCHEMBL5571747 0.86 ALDH1A1 (0.51) ALDH1A1SLC6A2SLC6A4GAANPSR1
SCHEMBL4777321 0.86 ALDH1A1 (0.54) ALDH1A1GAAHTR1ASMN1; SMN2LMNA
SCHEMBL5571881 0.85 ALDH1A1 (0.51) ALDH1A1SLC6A2SLC6A4GAANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070135435-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-06-14 US claimed
EP-1942888-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Cytokinetics, Inc. (US) 2008-07-16 EP disclosed
US-20070135435-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-06-14 US disclosed
WO-2007056078-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. (US) 2007-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135435-A1 Certain chemical entities, compositions, and methods KIF5B, KIF2C, PLK1 ALDH1A1 2159/4885SLC6A2 3818/4885SLC6A4 3990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.